Literature DB >> 11224185

Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure.

S.L. Peters1, M.H. Joseph.   

Abstract

Latent inhibition (LI) reflects a cognitive process whereby repeated pre-exposure of a to-be-conditioned stimulus impairs subsequent conditioning. Since it is believed to reflect the ability of an organism to screen out irrelevant stimuli, disrupted LI has been suggested as a model for a cognitive deficit in schizophrenia. Animal studies have previously shown that indirect dopamine (DA) agonists can disrupt LI, an effect which is reversed by neuroleptics. Conversely, neuroleptics given alone potentiate LI. In this study, using pre-exposure to a tone stimulus which is subsequently paired with mild footshock, we have demonstrated that haloperidol given before conditioning only is equally as effective as haloperidol given twice, before pre-exposure and conditioning, in potentiating LI after 10 pre-exposures. This supports our earlier results with nicotine, pointing to conditioning as the critical time for the action of dopaminergic manipulations on LI. The implications for the use of potentiated LI as a screening test for neuroleptic action are discussed.

Entities:  

Year:  1993        PMID: 11224185     DOI: 10.1097/00008877-199304000-00011

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  9 in total

1.  Latent inhibition: interpretation of amphetamine effects in novel paradigms.

Authors:  M H Joseph
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

2.  Habituation, latent inhibition, and extinction.

Authors:  Wesley P Jordan; Travis P Todd; David J Bucci; Robert N Leaton
Journal:  Learn Behav       Date:  2015-06       Impact factor: 1.986

3.  Effects of nicotine and amphetamine on latent inhibition in human subjects.

Authors:  J C Thornton; S Dawe; C Lee; C Capstick; P J Corr; P Cotter; S Frangou; N S Gray; M A Russell; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

Review 4.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

5.  Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat.

Authors:  C W Stevenson; Alain Gratton
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

6.  Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.

Authors:  Holger Russig; Aneta Kovacevic; Carol A Murphy; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2003-07-25       Impact factor: 4.530

7.  Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.

Authors:  L M McDonald; P M Moran; G N Vythelingum; M H Joseph; J D Stephenson; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

8.  Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms: evidence for dopamine-reinforcer interactions.

Authors:  A S Killcross; A Dickinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

9.  Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

Authors:  A S Killcross; A Dickinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.